{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T19:43:19Z","timestamp":1780429399483,"version":"3.54.1"},"reference-count":61,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T00:00:00Z","timestamp":1614816000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brit J Clinical Pharma"],"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:p>From rat studies, human case reports and cohort studies, bisphosphonates seem to impair renal function. However, when critically reviewing the literature, zoledronate and pamidronate are more frequently involved in renal deterioration than other bisphosphonates. When bisphosphonate nephropathy occurs, zoledronate more frequently induces tubular toxicity whereas pamidronate typically induces focal segmental glomerulosclerosis. Thus, although bisphosphonates are highly effective in preventing complications for patients with osseous metastases and are highly effective in preventing fractures for patients with osteoporosis, renal function should be monitored closely after initiation of these drugs.<\/jats:p>","DOI":"10.1111\/bcp.14780","type":"journal-article","created":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T03:37:12Z","timestamp":1613619432000},"page":"3485-3491","source":"Crossref","is-referenced-by-count":33,"title":["Bisphosphonate nephropathy: A case series and review of the literature"],"prefix":"10.1111","volume":"87","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6369-8341","authenticated-orcid":false,"given":"Camiel","family":"de Roij van Zuijdewijn","sequence":"first","affiliation":[{"name":"Department of Internal Medicine Spaarne Gasthuis  Haarlem\/Hoofddorp the Netherlands"},{"name":"Department of Nephrology &amp; Amsterdam Cardiovascular Sciences, Amsterdam UMC Vrije Universiteit Amsterdam  Amsterdam the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"van Dorp","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine Spaarne Gasthuis  Haarlem\/Hoofddorp the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9676-1722","authenticated-orcid":false,"given":"Sandrine","family":"Florquin","sequence":"additional","affiliation":[{"name":"Department of Pathology &amp; Amsterdam Cardiovascular Sciences, Amsterdam UMC University of Amsterdam  Amsterdam the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9595-6571","authenticated-orcid":false,"given":"Joris","family":"Roelofs","sequence":"additional","affiliation":[{"name":"Department of Pathology &amp; Amsterdam Cardiovascular Sciences, Amsterdam UMC University of Amsterdam  Amsterdam the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kees","family":"Verburgh","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine Spaarne Gasthuis  Haarlem\/Hoofddorp the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,3,4]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S8756-3282(99)00116-7"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2008.356"},{"key":"e_1_2_8_4_1","unstructured":"GIP\/Zorginstituut Nederland[www.gipdatabank.nl]"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2010.10.002"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1586\/17512433.2015.1099432"},{"issue":"1","key":"e_1_2_8_7_1","first-page":"S1","article-title":"The Concise Guide to PHARMACOLOGY 2019\/20: Introduction and Other Protein Targets","volume":"176","author":"Alexander SPH","year":"2019","journal-title":"Br J Pharmacol"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20000615)88:12 <2961::AID-CNCR12>3.0.CO;2-L"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2008.01.006"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002239900606"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(83)91465-4"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(85)92253-6"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0773.1997.tb01964.x"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199614030-00003"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V1261164"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00426.x"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2002.03826.x"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1080\/08998280.2007.11928298"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.10-10-842"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199602223340802"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(20000301)88:5<1082::AID-CNCR20>3.0.CO;2-Z"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01625440"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01623227"},{"issue":"8","key":"e_1_2_8_24_1","first-page":"315","article-title":"Intravenous pamidronate compared with oral alendronate for the treatment of postmenopausal osteoporosis","volume":"60","author":"Heijckmann AC","year":"2002","journal-title":"Neth J Med"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2015.04.016"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2003.00071.x"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfm209"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200310233491721"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.2011.000486"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1E589"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22504"},{"issue":"5","key":"e_1_2_8_32_1","first-page":"377","article-title":"Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double\u2010blind, comparative trial","volume":"7","author":"Rosen LS","year":"2001","journal-title":"Cancer J"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.04.105"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-008-0553-7"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011807"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa067312"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa074941"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2008.193"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.pcan.4500574"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdg367"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.07.054"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2354.2005.00641.x"},{"issue":"3","key":"e_1_2_8_43_1","first-page":"123","article-title":"High bone\u2010binding capacity of ibandronate in hemodialysis patients","volume":"25","author":"Bergner R","year":"2005","journal-title":"Int J Clin Pharmacol Res"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1159\/000094676"},{"issue":"3","key":"e_1_2_8_45_1","first-page":"488","article-title":"Efficacy and tolerability of intravenous ibandronate injections in postmenopausal osteoporosis: 2\u2010year results from the DIVA study","volume":"35","author":"Eisman JA","year":"2008","journal-title":"J Rheumatol"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2005.044958"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1081\/JDI-65397"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-007-0361-9"},{"key":"e_1_2_8_49_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-008-0078-x"},{"key":"e_1_2_8_50_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-011-1836-2"},{"key":"e_1_2_8_51_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2012.227"},{"key":"e_1_2_8_52_1","doi-asserted-by":"publisher","DOI":"10.1080\/08860220701260776"},{"key":"e_1_2_8_53_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-004-1075-4"},{"key":"e_1_2_8_54_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-015-2883-4"},{"key":"e_1_2_8_55_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-017-0478-9"},{"key":"e_1_2_8_56_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1993.102"},{"key":"e_1_2_8_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)62051-X"},{"key":"e_1_2_8_58_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13332"},{"key":"e_1_2_8_59_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2010.02.338"},{"key":"e_1_2_8_60_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.1075"},{"key":"e_1_2_8_61_1","unstructured":"www.geneesmiddeleninformatiebank.nl"},{"key":"e_1_2_8_62_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkaa971"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bcp.14780","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/bcp.14780","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bcp.14780","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T21:44:23Z","timestamp":1693345463000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/bcp.14780"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,4]]},"references-count":61,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["10.1111\/bcp.14780"],"URL":"https:\/\/doi.org\/10.1111\/bcp.14780","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"value":"0306-5251","type":"print"},{"value":"1365-2125","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,4]]}}}